Concepedia

Venkata Sasikiran Goteti

VS

6

Publications

510

Citations

6

H-Index

2010

Active since

Affiliations

Cedars-Sinai Medical Center(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Cornell University

Hôpital Saint Joseph

Johns Hopkins Medicine

Venkata Sasikiran Goteti is an author at Cedars-Sinai Medical Center specializing in medicine, hepatitis, and virology.

Top concepts

Publications per year

2010–2022

6

Publications

6

Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir

Fred Poordad, Jean–Pierre Bronowicki, Stuart C. Gordon et al. · Gastroenterology · 2012 · 193 citations · Full text

, , +9

Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy†,‡

Stephen A. Harrison, Lorenzo Rossaro, Ke-Qin Hu et al. · Hepatology · 2010 · 144 citations

Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results

Geert D’Haens, William J. Sandborn, Edward V. Loftus et al. · Gastroenterology · 2022 · 79 citations · Full text

Boceprevir With Peginterferon Alfa-2a–Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection

Steven L. Flamm, Eric Lawitz, Ira M. Jacobson et al. · Clinical Gastroenterology and Hepatology · 2012 · 63 citations

, , +7

1366 HIGH SUSTAINED VIROLOGIC RESPONSE (SVR) AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN

S. Flamm, E. Läwitz, Ira M. Jacobson et al. · Journal of Hepatology · 2011 · 21 citations

, , +9

Rows per page

1–5 of 6